Lack of acute cyclosporine nephrotoxicity in late heart-transplant recipients

被引:6
作者
Piquard, F [1 ]
Geny, B
Hardy, H
Chakfe, N
Mettauer, B
Charloux, A
Lampert, E
Lonsdorfer, J
机构
[1] Fac Med Strasbourg, Inst Physiol, Lab Regulat Physiol & Rythmes Biol Homme, F-67085 Strasbourg, France
[2] Hop Univ, Serv Explorat Fonctionnelles Physiol, Strasbourg, France
关键词
D O I
10.1016/S1053-2498(00)00092-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cyclosporine induces daily renal hypoperfusion in subjects with normal atrial natriuretic peptide (ANP) levels, but its acute effects in heart transplant patients with increased ANP remain to be determined. Methods: Cyclosporinemia and creatinine clearance were monitored during 7 hours following cyclosporine administration in 6 heart transplant patients. Results-Conclusions: No acute cyclosporine-induced decrease in creatinine clearance was observed after heart transplantation. These data suggest that maintenance cyclosporine dose may be less nephrotoxic than suspected and that increased ANP might protect the renal function late after heart transplantation.
引用
收藏
页码:507 / 509
页数:3
相关论文
共 9 条
[1]   DIVERSE BIOLOGICAL ACTIONS OF ATRIAL-NATRIURETIC-PEPTIDE [J].
BRENNER, BM ;
BALLERMANN, BJ ;
GUNNING, ME ;
ZEIDEL, ML .
PHYSIOLOGICAL REVIEWS, 1990, 70 (03) :665-699
[2]   Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients [J].
Geny, B ;
Hardy, H ;
Lonsdorfer, J ;
Eisenmann, B ;
Haberey, P ;
Piquard, F .
HYPERTENSION, 1999, 33 (04) :969-974
[3]  
Goral S, 1997, J HEART LUNG TRANSPL, V16, P1106
[4]   Cyclosporine-induced hypertension and decline in renal function in healthy volunteers [J].
Hansen, JM ;
FoghAndersen, N ;
Christensen, NJ ;
Strandgaard, S .
JOURNAL OF HYPERTENSION, 1997, 15 (03) :319-326
[5]   CYCLOSPORINE THERAPY AFTER CARDIAC TRANSPLANTATION CAUSES HYPERTENSION AND RENAL VASOCONSTRICTION WITHOUT SYMPATHETIC ACTIVATION [J].
KAYE, D ;
THOMPSON, J ;
JENNINGS, G ;
ESLER, M .
CIRCULATION, 1993, 88 (03) :1101-1109
[6]   Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients [J].
Lipkin, GW ;
Thuraisingham, R ;
Dawnay, ABS ;
Harwood, SM ;
Raine, AEG .
TRANSPLANTATION, 1997, 64 (07) :1007-1017
[7]   DAILY RENAL HYPOPERFUSION INDUCED BY CYCLOSPORINE IN PATIENTS WITH RENAL-TRANSPLANTATION [J].
PERICO, N ;
RUGGENENTI, P ;
GASPARI, F ;
MOSCONI, L ;
BENIGNI, A ;
AMUCHASTEGUI, CS ;
GASPARINI, F ;
REMUZZI, G .
TRANSPLANTATION, 1992, 54 (01) :56-60
[8]   Role of immunosuppressive therapy in neuroendocrine activation after human heart, renal, and liver transplantation [J].
Piquard, F ;
Geny, B ;
Elero, B ;
Canguilhem, B ;
Mettauer, B ;
Epailly, E ;
Chakfe, N ;
Charpentier, A ;
Wolf, P ;
Kretz, JG ;
Eisenmann, B ;
Koehl, C ;
Haberey, P .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) :2124-2126
[9]   A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus [J].
Taylor, DO ;
Barr, ML ;
Radovancevic, B ;
Renlund, DG ;
Mentzer, RM ;
Smart, FW ;
Tolman, DE ;
Frazier, OH ;
Young, JB ;
VanVeldhuisen, P .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (04) :336-345